Man in suit shrugging
Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Harvey Norman (ASX:HVN) has confirmed it’s been hit by a second class action this week over allegedly dodgy warranty cover – and the stock is up +1.23 at 11.15am Sydney time.

Earlier this week, Mr. H Norman was slapped with a class action from Echo Law.

The one-sentence-version: HVN is being accused of selling warranties to customers they already had access to under Australian Consumer Law (ACL) for free.

Under ACL, sort of poetically, that’s illegal.

Echo Law led that first class action. But now there’s another one coming from Maurice Blackburn, confirmed in the surprisingly diverse ecosystem that is law industry trade publications.

Maurice Blackburn principal Jarrah Ekstein told Lawyers Weekly – in his own words – Harvey Norman has been misleading customers, straight up, no doubt about it.

So why the hell are shares going up? Well, the answer isn’t really too surprising.

The company is obviously the beneficiary of improved consumer sector sentiment, given the chunky US rate cuts we’ve just seen from the Fed of -50bps. So that’s perhaps unsurprising.

There’s also the “cost of doing business” aspect, if you’re cynical.

Harvey Norman is a multi-billion dollar market cap company and the still-not-hugely-clear compensatory amounts being sought after are, according to one industry publication, limited to the “hundreds of millions [of dollars].”

Try telling someone without hundreds of millions of dollars that it isn’t “that much” money. But you get what I mean – HVN has survived any kind of shock sell-off (think about the recent Four Corners effect on Steadfast’s share price.)

HVN last traded at $4.94/sh.

hvn by the numbers
More From The Market Online
HotCopper Daily Market Trends Graphic

Friday’s HotCopper trends: Buru Energy, Invictus Energy, BPM Minerals and other daily topics

With more than 600k average monthly users on the HotCopper forums, each and every discussion can…

PYC Therapeutics doses first patient in OLE study supporting kidney disease candidate

PYC Therapeutics has dosed the first patient in a Part D open-label extension (OLE) of an…

Auravelle Metals commences gold discovery aircore program at Nuckulla Hill

Auravelle Metals has commenced testing new drill targets at the Nuckulla Hill gold project in South…

BPM Minerals granted Bonnie and Clyde drilling approvals

BPM Minerals has received the final key approval allowing for the maiden Bonnie & Clyde drilling…